Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2011-07-12
2011-07-12
Katakam, Sudhakar (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C514S626000, C514S511000
Reexamination Certificate
active
07977511
ABSTRACT:
This invention concerns compounds of adamantanamines and neramexane, including their pharmaceutically-acceptable salts, diesterioisomers, and formulations for treating Alzheimer's related dementias, depression, AIDS related dementias, as antivirals, inflammatory diseases such as rheumatoid arthritis, and cerebral ischemia, hyperlipidemia, and diabetes.
REFERENCES:
patent: 2003/0114460 (2003-06-01), Hughes et al.
patent: 2005/0049312 (2005-03-01), Makovec et al.
Blair Jarvis and David P. Figgitt, “Memantine”, Drugs Aging 20(6), 465-476 (2003), Adis Data Information BV 2003.
Barry Reisberg, MD et al., “Memantine in Moderate-to-Severe Alzheimer's Disease”, N Engl. J. of Med. 348, 1333-1341 (2003), Mass. Medical Society.
C.G. Parsons et al., “Memantine is a Clinically Well Tolerated NMDA Receptor Antagonist—a Review of Preclinical Data”, Neutopharmacology 38, 735-767 (1999), Pergamon.
Gordon K. Wilcock, “Memantine for the Treatment of Dementia”, The Lancet, Neurology 2, 503-505 (Aug. 2003).
A. Bianchetti et al., “Effects of Acetyl-L-carnitine in Alzheimer's disease patients unresponsive to AChE-l”, Curr. Med. Res. and Opinion 19(4), 350-353 (2003), Librapharm Ltd.
A. Spagnoli, MD et al., “Long-term Acetyl-L-carnitine Treatment in Alzheimer's Disease”, Neurology 41, 1726-1732 (1991).
J. David Leander et al., “N-Methyl-D-aspartic acid-induced lethality in mice:selective antagonism by phencyclidine-like drugs”, Brain Res. 448, 115-120 (1988), Elsevier Sci.
C.G. Parsons et al., Neuropharmacology 34(10),1239-1256 (1995), Elsevier Sci.
Katakam Sudhakar
Kimble Karen L.
SSV Therapeutics, Inc.
Technology Law PLLC
LandOfFree
Carnitine conjugates of adamantanamines and neramexane... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carnitine conjugates of adamantanamines and neramexane..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carnitine conjugates of adamantanamines and neramexane... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2713836